Skip to main content
Back to News
VLab Corporation unveiled Variation 2.0 on January 26, 2026, an AI platform that identifies root cau...
Product
1 min read
US

VLab Corporation unveiled Variation 2.0 on January 26, 2026, an AI platform that identifies root cau...

The AMW Read

The article provides an incremental update on VLab Corporation's product roadmap (Variation 2.0) and its application within the musculoskeletal rehabilitation vertical.
NoveltySignificance
Healthcare & Bio Β· Player Map

VLab Corporation unveiled Variation 2.0 on January 26, 2026, an AI platform that identifies root causes of musculoskeletal pain by backtracking symptom data. Recently selected for the 2025 TIPS Global Track, the startup is preparing for a March 2026 app store launch to digitize professional rehabilitation workflows. The system integrates automated sequence builders scheduled for sequential release throughout 2026. This technology shifts the wellness industry from subjective instruction to a data-driven clinical model. πŸ§˜β€β™‚οΈπŸ’»

#AI #HealthTech #Pilates #VLab #RehabTech

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 1d agoSkyLabs Sets September KOSDAQ Listing, Discloses $18.4M H1 2026 Revenue and Otsuka Distribution DealSkyLabs
  2. 5d agoVivodyne, a biotech startup spun out of the University of Pennsylvania in 2021, has unveiled HIVE, a...Vivodyne
  3. 5d agoGenBio AI, a Palo Alto-based AI company co-founded by Nobel laureate David Baker, has released AIDO...GenBio AI
  4. 7mo agoVLab Corporation unveiled Variation 2.0 on January 26, 2026, an AI platform that identifies root cau... Β· THIS ARTICLE

Related News

More news from January

Stay updated with the latest news and announcements from January.

View all January news

Discover AI Startups

Explore 5,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard